Shortened Hospital Stay and Improvement of Inpatient Management for Decompensated Heart Failure Patients

Heart failure constitutes a pandemic health condition that is distinguished by its association with high morbidity and mortality statistics. Acute heart failure episodes necessitating hospital admission are characterised by poor clinical outcomes and increased hospitalisation duration, particularly within the context of an ageing demographic. While standard therapeutic regimens encompass IV diuretics, ARNIs (angiotensin II receptor blockers and a neprilysin inhibitor), beta-blockers, mineralocorticoid receptor antagonists, and SGLT2 (sodium-glucose cotransporter-2) inhibitors, insufficient monitoring and modification of clinical and biochemical indicators contribute to extended hospital stays and increased adverse event rates.